Overall, these data reveal that METTL1 and WDR4 are significantly up-regulated in AML patients and associated with AML progression, suggesting the potential clinical significance of METTL1 and WDR4 in AML. The gene discussed is METTL1; the disease is acute myeloid leukemia.